Skip to search boxSkip to navigationSkip to main content

Mesh fixation with autologous platelet-rich fibrin sealant in inguinal hernia repair

  • I.H.J.T. de Hingh
    ,
  • ,
  • E.P. Overdevest
    ,
  • K. Scheele
    ,
  • P.A.M. Everts
  • Catharina Hospital
Output:
Contribution to journal
Article
Academic
Peer-review

Information

Output type

Output:
Contribution to journal
Article
Academic
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 306-309 (4 pages)

Journal (Volume, Issue Number)

European Surgical Research (Volume 43, Issue 3)

Publication milestones

  • Published - 09/2009

Publication status

Published - 09/2009

ISSN

0014-312X

Abstract

BACKGROUND: Chronic pain is the main complication following inguinal hernia repair. A possible explanatory factor is the suture fixation of the mesh. Glue fixation might overcome this problem. Albeit at a very low frequency, human and bovine components of fibrin sealants currently available could contain blood-borne pathogens. Autologous platelet-rich fibrin sealant (P-RFS) eliminates this risk and has additional advantages such as hemostatic and antibacterial effects. Therefore, its feasibility was assessed in inguinal hernia repair, with a focus on pain.

METHODS: In 22 patients with primary inguinal hernia, the mesh was fixated with P-RFS. Data included operative variables, complications, pain scores and neurological examinations. Long-term follow-up was 22.2 months (SD 2.2) postoperatively.

RESULTS: After 2 weeks, visual analogue scale and disability pain scores were lower than they were preoperatively. Complications at 3 months were 1 recurrence, 1 chronic pain and 6 sensory disturbances. At the last clinical evaluation, the recurrence was planned for repair due to discomfort. No chronic pain, sensory disorders or discomfort was reported at long-term follow-up.

CONCLUSION: Mesh fixation with autologous P-RFS is feasible. If there is a preference for autologous material, P-RFS is indicated. If glue fixation becomes standard, further randomized studies are warranted for this alternative.

Metrics

Metrics

SciVal
citations
12
SciVal
FWCI
0.63
SciVal
Author count
5
SciVal
Paper percentile
61
Scopus
citations
12

PlumX, opens in new tab

Citation count
12
Captures
40